3 Stocks I Saw on T...
Cubist Pharmaceuticals Inc. (CBST: NASDAQ)
$39.93 0.26 | 0.66%
06/04/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 753.97M | 636.46M | 562.14M | 433.64M |
| Cost of Sales | 132.62M | 104.99M | 89.86M | 79.67M |
| Gross Operating Profit | 621.35M | 531.46M | 472.29M | 353.97M |
| Selling, General, and Administrative Expenses | 254.76M | 148.24M | 136.92M | 125.70M |
| Research & Development | 184.53M | 157.85M | 170.58M | 126.67M |
| Operating Income before D & A (EBITDA) | 182.06M | 225.37M | 164.79M | 101.60M |
| Depreciation & Amortization | 40.25M | 35.77M | 27.03M | 10.71M |
| Interest Income | 2.67M | 4.70M | 4.26M | 10.07M |
| Other Income - Net | 1.00M | -14.41M | -1.23M | -45.71M |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | 136.20M | 179.89M | 140.79M | 55.24M |
| Interest Expense | 31.42M | 25.58M | 20.89M | 9.34M |
| Pre-Tax Income | 104.79M | 154.31M | 119.90M | 45.90M |
| Income Taxes | 71.77M | 59.98M | 40.30M | -123.92M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | 33.02M | 94.32M | 79.60M | 169.82M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | 33.02M | 94.32M | 79.60M | 169.82M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 33.02M | 94.32M | 79.60M | 169.82M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
42.30M | 94.32M | 79.60M | 169.82M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 33.02M | 94.32M | 79.60M | 169.82M |
| Basic EPS from Continuing Ops. | 0.54 | 1.60 | 1.38 | 3.00 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 0.54 | 1.60 | 1.38 | 3.00 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 0.54 | 1.60 | 1.38 | 3.00 |
| Basic Normalized Net Income/Share | 0.69 | 1.60 | 1.38 | 3.00 |
| EPS fr Continuing Ops. | 0.52 | 1.55 | 1.36 | 2.56 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | 0.52 | 1.55 | 1.36 | 2.56 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 0.52 | 1.55 | 1.36 | 2.56 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0.67 | 1.55 | 1.36 | 2.56 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with CBST
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- UserGFNN Stockdiagnostics 6
- ContributorStocks At New 52-Week Highs...
- ContributorTop-Rated Biotechnology Stocks
- ContributorEarnings Short Squeeze Play...
- ContributorStocks At New 52-Week Highs...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ProJoel Greenblatt - Gotham Ca...
- ContributorEarnings Short Squeeze Play...
Latest CBST Headlines from TheStreet
- Upgrades Roundup: TXT, CBST, BK, MCP, AVP, LFL, SHO, BPI 04.23.12 | 06:04 am
- Cubist Pharmaceuticals Inc. Stock Upgraded (CBST) 04.20.12 | 05:04 am
- 5 Stocks Poised to Pop on Earnings 04.18.12 | 07:04 am
- Cubist Stock Hits New 52-Week High (CBST) 03.26.12 | 11:03 am
- Cubist Stock Hits New 52-Week High (CBST) 03.09.12 | 10:03 am
- Cubist Reaches New 52-Week High (CBST) 02.22.12 | 03:02 pm
- Cubist Stock Hits New 52-Week High (CBST) 02.03.12 | 10:02 am
- TheStreet Ratings Top 10 Rating Changes 01.23.12 | 12:01 pm
- Cubist Pharmaceuticals Inc. Stock Downgraded (CBST) 01.23.12 | 05:01 am
- 5 Stocks Set to Soar on Bullish Earnings 01.18.12 | 03:01 pm
Press Releases for CBST
- Cubist Pharmaceuticals Marks 20th Anniversary By Making Its Largest-Ever Commitment To STEM Programs - Business Wire 05.16.12 | 09:05 am
- Cubist Pharmaceuticals To Present At May Investor Conference - Business Wire 05.07.12 | 10:05 am
- Cubist Announces Positive Results From ENTEREG® Phase 4 Study In Patients Undergoing Radical Cystectomy - Business Wire 04.17.12 | 05:04 pm
- Cubist Pharmaceuticals To Announce Q112 Financial Results On Wednesday, April 18th, 2012 - Business Wire 04.02.12 | 10:04 am
- Senator Scott Brown And Cubist Pharmaceutical President And CEO Michael Bonney (right) And Steven Gilman, Executive Vice President, Research & Development And Chief Scientific Officer. - Business Wire 03.16.12 | 12:03 pm
- Cubist Pharmaceuticals Appoints Jane Henney To Board Of Directors - Business Wire 03.09.12 | 08:03 am
- Cubist Pharmaceuticals To Present At February/March Investor Conferences - Business Wire 02.20.12 | 11:02 am
- Cubist Pharmaceuticals Appoints Alison Lawton To Board Of Directors - Business Wire 02.16.12 | 08:02 am
- Cubist Receives CUBICIN Paragraph IV Notice Letter - Business Wire 02.09.12 | 07:02 am
- Cubist Pharmaceuticals Reports 2011 Fourth Quarter And Full Year Financial Results - Business Wire 01.19.12 | 04:01 pm
Partner Headlines for CBST
- After Hours Most Active for Jun 1, 2012 : BAC, QQQ, MSFT, JPM, KITD, SWK, WFC, WMB, MET, STX, CBST, INTC - NASDAQ 06.01.12 | 08:06 pm
- The Definitive Biotech ETF Guide (IBB, XBI, FBT) - Benzinga 05.21.12 | 01:05 pm
- Medical Stocks Forming Bases Amid Market Sell-Off - Investor's Business Daily 05.18.12 | 06:05 pm
- Big Pharma Abandons Antibiotics: An Opening For Small Biotech - Seeking Alpha 05.13.12 | 09:05 am
- 2 Low-Growth Pharma Behemoths: Merck, J&J - Seeking Alpha 05.01.12 | 09:05 am
- Kinetics Hedge Fund's Top Undervalued Picks - Seeking Alpha 03.23.12 | 05:03 pm
- Alnylam Delivers In-Line Numbers - Analyst Blog - Zacks 02.13.12 | 10:02 am
- 10 Stocks That Made New Highs On Friday: Hedging Costs - Seeking Alpha 01.15.12 | 07:01 am
- Cubist's Preliminary Sales Impress - Analyst Blog - Zacks 01.11.12 | 10:01 am
- Alnylam States Preclinical Data - Analyst Blog - Zacks 12.30.11 | 04:12 pm





